You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 12, December 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Complement in Chronic Secretory Otitis Media

C3 Breakdown and C3 Splitting Activity

Seppo Meri, MD; Tessa Lehtinen, MA; Tauno Palva, MD

Arch Otolaryngol. 1984;110(12):774-778.


Abstract

• Occurrence of in vivo C3 breakdown and in vitro C3 splitting activity was studied in serum and middle-ear effusion (MEE) samples from 30 children with chronic secretory otitis media (SOM). The MEE showed strongly elevated levels of both low- and high-molecular-weight C3 breakdown products, along with decreased factor B, C4, and C3 levels. Total hemolytic complement component activity was virtually absent from MEE. The MEE fluids were found to contain C3 splitting factors as demonstrated by their high capacity to convert C3 in vitro from fresh normal human serum. This activity was not inhibited by the classic complement pathway inhibitor, 0.01M ethylene glycol tetra-acetic acid with 0.005M magnesium chloride. The results suggest that a strong local complement activation has taken place and that the factors responsible are present in the MEE of patients with SOM.

(Arch Otolaryngol 1984;110:774-778)



Author Affiliations

From the Departments of Bacteriology and Immunology (Dr Meri) and Otolaryngology (Ms Lehtinen and Dr Palva), University of Helsinki, Finland.


Footnotes

Accepted for publication June 5, 1984.

Reprint requests to Department of Otolaryngology, University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland (Dr Palva).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ionic Binding of C3 to the Human Pathogen Moraxella catarrhalis Is a Unique Mechanism for Combating Innate Immunity
Nordstrom et al.
J. Immunol. 2005;175:3628-3636.
ABSTRACT | FULL TEXT  

Analysis of Immunocompetent Cells in the Middle Ear Mucosa
Ichimiya et al.
Arch Otolaryngol Head Neck Surg 1990;116:324-330.
ABSTRACT  

Plasmin and Fibronectin Degradation in Chronic Secretory Otitis Media
Salonen et al.
Arch Otolaryngol Head Neck Surg 1989;115:48-53.
ABSTRACT  

Tumor Necrosis Factor in Middle Ear Effusions
Ophir et al.
Arch Otolaryngol Head Neck Surg 1988;114:1256-1258.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.